{"id":194277,"date":"2025-06-18T11:36:20","date_gmt":"2025-06-18T11:36:20","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/194277\/"},"modified":"2025-06-18T11:36:20","modified_gmt":"2025-06-18T11:36:20","slug":"ricoh-usa-establishes-ricoh-3d-for-healthcare-llc","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/194277\/","title":{"rendered":"Ricoh USA establishes Ricoh 3D for Healthcare, LLC"},"content":{"rendered":"

Ricoh\u00a0USA, Inc.<\/a><\/strong> has announced the formation of a new company, Ricoh 3D for Healthcare, LLC<\/a><\/strong>, dedicated to rapidly growing the adoption of FDA-cleared, patient-specific medical devices. With hospitals facing rising pressure to deliver patient-specific medical devices quickly and efficiently,\u00a0Ricoh<\/a> says it\u00a0is committed to democratising access to advanced healthcare technologies, empowering hospitals to move up the value chain. <\/p>\n

Driven by a rising demand for customised and patient-specific solutions according to the company, the market for 3D printed medical devices is projected to grow\u00a0from\u00a05.59 billion USD\u00a0in 2025 to\u00a024.69 billion USD\u00a0by 2034<\/a>. This new company will provide greater agility to address this rapid growth, focus on the unique needs of clinical customers, and help drive regulatory guidance and standardisation.<\/p>\n

\u201cThe establishment of Ricoh 3D for Healthcare is the natural next step in the evolution of a business Ricoh has been incubating for five years,\u201d said Gary Turner,\u00a0Vice President and General Manager, Ricoh 3D for Healthcare. \u201cAs we rapidly scale and enter an accelerated growth phase of the business, it is essential that we have the right structure in place to realise and maximise the potential that Ricoh has envisioned for this business from the beginning.\u201d<\/p>\n

Ricoh 3D for Healthcare delivers a full continuum of patient-specific solutions\u2014from FDA (Food and Drug Administration)-cleared anatomic models to on-site, point-of-care manufacturing studios that facilitate hospitals\u2019 ability to have regulated devices manufactured inside their own walls.<\/p>\n

Beyond hospital programs, Ricoh 3D for Healthcare collaborates with emerging medical technology innovators, such as\u00a0Kallisio (oral stents for head and neck cancer)<\/a>\u00a0and\u00a0Insight Surgery (oncology and osteotomy surgical guides)<\/a>,\u00a0to manufacture and distribute next-generation, patient-specific devices nationwide. These combined efforts position Ricoh 3D for Healthcare at the centre of a rapidly expanding ecosystem that is redefining personalised care.<\/p>\n

Precision healthcare is receiving increased attention. The FDA continues to develop regulatory frameworks for 3D<\/a>\u00a0as well as review and clear personalised 3D printed implants<\/a>\u00a0and surgical tools.\u00a0 Momentum is also building for reimbursement, with a growing number of CPT (Current Procedural Terminology) and HCPCS (Healthcare Common Procedure Coding System) codes<\/a>\u00a0to cover 3D visualisation, planning and printing.<\/p>\n

\u201cRicoh 3D for Healthcare is a pioneer in this industry. An example is our\u00a0point-of-care 3D medical device manufacturing facility<\/a>\u00a0at Atrium Health,\u00a0which gives clinicians immediate access to 3D printed anatomic models and support,\u201d said Turner. \u201cOur ability to operate independently will allow us to accelerate similar types of innovation, facilitating opportunities to partner, innovate and collaborate.\u201d<\/p>\n<\/p>\n

Like this:<\/p>\n

Like Loading…<\/p>\n

<\/p>\n

\n\tRelated<\/p>\n","protected":false},"excerpt":{"rendered":"Ricoh\u00a0USA, Inc. has announced the formation of a new company, Ricoh 3D for Healthcare, LLC, dedicated to rapidly…\n","protected":false},"author":2,"featured_media":194278,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5311],"tags":[51732,2460,79216,49,978,659],"class_list":{"0":"post-194277","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-united-states","8":"tag-3d-printing","9":"tag-fda","10":"tag-ricoh-3d-for-healthcare","11":"tag-united-states","12":"tag-us","13":"tag-usa"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114704166941649088","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/194277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=194277"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/194277\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/194278"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=194277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=194277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=194277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}